Does the racial-ethnic variation in prostate cancer risk have a hormonal basis?
- 1 April 1995
- Vol. 75 (S7) , 1778-1782
- https://doi.org/10.1002/1097-0142(19950401)75:7+<1778::aid-cncr2820751605>3.0.co;2-j
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Re: Prostate Cancer and the Androgen ReceptorJNCI Journal of the National Cancer Institute, 1994
- Do Diet and Androgens Alter Prostate Cancer Risk via a Common Etiologic Pathway?JNCI Journal of the National Cancer Institute, 1994
- Reduced transcriptional regulatory competence of the androgen receptor in X–linked spinal and bulbar muscular atrophyNature Genetics, 1993
- Unusual length polymorphism in human steroid 5α-reductase type 2 gene (SRD5A2)Human Molecular Genetics, 1993
- 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black malesThe Lancet, 1992
- Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groupsGenomics, 1992
- Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophyNature, 1991
- The clinical development of a 5α-reductase inhibitor, finasterideThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Family history and the risk of prostate cancerThe Prostate, 1990
- ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancerNature, 1983